Anavex Life Sciences Corp (AVXL)
Net Income Growth
75.87%
Quarterly · Period ending:
AVXL Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported75.87%period ending
Latest reported75.87%period ending
AVXL Quarterly Net Income YoY % (-141.85% → 75.87%)
Year-over-year change
High-resolution chart · PNG
AVXL net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 75.874% | |
| 52.3223% | |
| 53.0922% | |
| 15.4303% | |
| -8.4248% | |
| -6.1635% | |
| -40.4662% | |
| -14.5276% | |
| -8.2801% | |
| 19.5392% | |
| 33.5338% | |
| 29.0011% | |
| 8.792% | |
| -25.5723% | |
| -19.202% | |
| -21.9504% | |
| -21.485% | |
| -27.9893% | |
| -38.5395% | |
| -96.4419% | |
| -56.9406% | |
| -12.6926% | |
| -19.1619% | |
| -53.7663% | |
| 0.5413% | |
| 0.1408% | |
| 4.7373% | |
| 33.0334% | |
| -128.9067% | |
| -52.5014% | |
| -70.4718% | |
| -12.3867% | |
| 21.0776% | |
| -206.7629% | |
| -28.9992% | |
| 20.8332% | |
| -61.1389% | |
| 23.7204% | |
| 20.4286% | |
| -21.5582% | |
| 47.1645% | |
| -17.7372% | |
| -402.659% | |
| 44.7749% | |
| -320.2047% | |
| -69.293% | |
| -319.3633% | |
| -224.5449% | |
| -564.2071% | |
| -860.2828% | |
| 179.0791% | |
| -341.1839% | |
| 96.6556% | |
| 88.3432% | |
| 79.1453% | |
| 52.3405% | |
| -187.7107% | |
| 53.8528% | |
| -15.2593% | |
| 49.0692% | |
| 19.6781% | |
| -15.0655% | |
| -303.4873% | |
| -40.2076% | |
| -46.7315% | |
| -38.0863% | |
| 49.6132% | |
| 3.9232% | |
| 20.2736% | |
| -82.0151% | |
| 6.1926% | |
| -81.1276% | |
| -559.3423% | |
| -303.3062% | |
| -7,946.4091% | |
| -19,773.9705% | |
| -4,386.743% | |
| -3,528.8412% | |
| -30.285% | |
| 86.3058% | |
| 87.5706% | |
| 89.8026% | |
| -141.8503% |